Biomarkers in pulmonary embolism

@article{Shne2004BiomarkersIP,
  title={Biomarkers in pulmonary embolism},
  author={Maaike S{\"o}hne and Marije ten Wolde and Harry R B{\"u}ller},
  journal={Current Opinion in Cardiology},
  year={2004},
  volume={19},
  pages={558-562}
}
Purpose of review Controversy exists about the precise role of thrombolytic therapy in normotensive patients with pulmonary embolism. To resolve this controversy two major questions must be addressed. First, can a subgroup of normotensive pulmonary embolism patients with a high risk for adverse outcomes, such as in-hospital mortality or early recurrent venous thromboembolism, be identified? Second, is there convincing evidence that the benefits of more aggressive therapy counterbalance its… Expand
Natriuretic peptides in acute pulmonary embolism: a systematic review
TLDR
It is indicated that BNP and NT-proBNP are associated with the diagnosis of right ventricular dysfunction (RVD) in patients with an acute PE and are significant predictors of all-cause in-hospital or short-term mortality in these patients. Expand
Biomarker-based risk assessment model in acute pulmonary embolism.
TLDR
Simultaneous measurement of serum cTnT and NT-proBNP allows for precise APE prognosis, whereas echocardiographic parameters were non-significant and did not improve group selection. Expand
Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?
TLDR
There is no evidence that thrombolysis has a benefit over standard anticoagulant treatment in normotensive patients with acute PE, but more research is needed to better identify the subgroup of patients with nonmassive PE in whom the risk-benefit ratio is most favorable. Expand
Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism.
TLDR
The Pulmonary Embolism Severity Index (PESI) reliably identifies patients with PE who are at low risk of death and who are potential candidates for outpatient care and may help physicians make more rational decisions about hospitalization for patients withPE. Expand
Natriuretic peptide type-B can be a marker of reperfusion in patients with pulmonary thromboembolism subjected to invasive treatment
TLDR
In patients with high-risk pulmonary embolism, natriuretic peptide type-B plasma levels experience rapid and significant reduction after successful invasive treatment, and serial measurements of NT-proBNP could be useful as a tracking tool to assess the success or failure of the thrombolytic treatment. Expand
D-dimer as a Prognostic Tool in Patients with Normotensive Pulmonary Embolism
TLDR
It is suggested that D-dimer levels below 2.76 μ g/mL have a low risk of MACEs, and may be used to identify low risk patients with normotensive PE. Expand
Can elevated troponin I levels predict complicated clinical course and inhospital mortality in patients with acute pulmonary embolism
TLDR
The results indicate that elevated cTnI levels are associated with higher risk for inhospital mortality and complicated clinical course, and Troponin I may play an important role for the risk assessment of patients with PE. Expand
Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism.
TLDR
Natriuretic peptides prevalence elevation and median values are significantly higher when RVD is present and significantly correlate with hCT RVD. Expand
Péptido natriurético cerebral como marcador de mal pronóstico en pacientes con tromboembolia pulmonar aguda
TLDR
The brain peptide natriuretic is a very important biomarker with a lot of utility in approach of patients with suspected pulmonary embolism and is significantly associated with mortality. Expand
The non-cardiac use and significance of cardiac troponins
  • G. Mannu
  • Medicine
  • Scottish medical journal
  • 2014
TLDR
The history of cardiac markers is described along with a discussion of the various causes of elevated cardiac troponins outside acute coronary syndrome and the applications and significance of this blood test and the potential uses of positive results with elevated serum Troponin levels are elaborate. Expand
...
1
2
...

References

SHOWING 1-10 OF 27 REFERENCES
Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism
TLDR
This is the first study to show that plasma BNP levels seem to predict adverse outcome in patients with acute pulmonary embolism. Expand
Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism
TLDR
Low BNP levels do not guarantee an uncomplicated hospital course in patients with acute PE, using a “congestive heart failure” cut-off level of 90 pg/mL, which identifies 95% of patients with a benign clinical course. Expand
Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary Embolism
TLDR
Low proBNP levels predict an uneventful hospital course in patients with acute PE, which identifies patients who will be potential candidates for an abbreviated hospital length of stay or care on a completely outpatient basis. Expand
Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism
TLDR
Cardiac troponins I and cTnT may be a novel, particularly useful tool for optimizing the management strategy in patients with acute PE, and there was obvious escalation of in-hospital mortality, the rate of complications, and the incidence of recurrent PE. Expand
Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism.
TLDR
Patients with PE and elevated cTnT levels detected during repetitive assays are at a significant risk of a complicated clinical course and fatal outcome. Expand
Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism.
TLDR
Cardiac troponin T may improve risk stratification in patients with PE and may aid in the identification of patients in whom a more aggressive therapy may be warranted. Expand
Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism.
TLDR
While troponin I measurements added most of the prognostic information for identifying high-risk patients, a normal echocardiogram combined with a negative tropon in I level was most useful to identify patients at lowest risk for early death. Expand
Elevated cardiac troponin levels in patients with submassive pulmonary embolism.
TLDR
Pulmonary embolism should be considered in the differential diagnosis of patients presenting with undifferentiated chest pain or dyspnea and an elevated cardiac troponin level, according to a prospective cohort study. Expand
Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction.
TLDR
Tronin I tests helped to identify patients with RV dilatation who had significantly more segmental defects in lung scans, demonstrating that troponin I assays are useful to detect minor myocardial damage in pulmonary embolism. Expand
Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study
TLDR
This work assessed the association between serum concentrations of cardiac troponin T and severity of pulmonary embolism as well as the role of trop onin T as a predictor of mortality in 136 consecutive patients admitted to the emergency department of a tertiary care university hospital between December 1999 and November 2001. Expand
...
1
2
3
...